SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-22-032947
Filing Date
2022-09-09
Accepted
2022-09-09 17:26:27
Documents
4
Period of Report
2022-10-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20005049x1_pre14a.htm PRE 14A 700190
2 logo_atai.jpg GRAPHIC 43339
3 ny20005049x1_pc01.jpg GRAPHIC 508782
4 ny20005049x1_pc02.jpg GRAPHIC 832362
  Complete submission text file 0001140361-22-032947.txt   2607063
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40493 | Film No.: 221236932
SIC: 2834 Pharmaceutical Preparations